PCA(P)(2026)01 - Creon® Serious Shortage Protocol Extension
Published: 19th January 2026
Community pharmacy teams should be aware of updated Serious Shortage Protocol (SSP) extensions relating to Creon® gastro‑resistant capsules. These changes affect supply timeframes and require pharmacists to apply professional judgement while continuing to follow all existing protocol conditions.
Extension to Serious Shortage Protocols for Creon® Gastro‑Resistant Capsules
This Circular advises Health Boards and community pharmacy contractors that two UK‑wide Serious Shortage Protocols (SSPs) for Creon® gastro‑resistant capsules, both due to expire on 16 January 2026, have been extended.
The extension applies to SSP060 (Creon® 10000), which has been extended until Friday 30 January 2026, and SSP061 (Creon® 25000), which has been extended until Friday 17 April 2026. All other terms of these two SSPs remain unchanged. Under both SSPs, community pharmacists may continue to restrict the total quantity supplied to one month’s supply of the prescribed medicine.
Community pharmacists are advised to review and familiarise themselves with the new end dates for the above‑noted SSPs.
Background
To assist in alleviating current supply issues with medicines availability, various UK‑wide SSPs have been issued by the Department of Health and Social Care (DHSC), in consultation with the Scottish Government. An SSP is an additional tool to manage and mitigate medication shortages for prescribing clinicians, community pharmacies and importantly patients.
Each SSP is individually developed and clinically authorised to enable community pharmacists and dispensing doctors to dispense a different strength or formulation or an alternative medicine or appliance in accordance with the protocol, rather than having to refer prescribing decisions back to the original prescriber. These protocols are time‑limited.
Community pharmacists are expected to use their professional skill and judgement to decide whether it is reasonable and appropriate to substitute a person’s prescribed medicine using the SSP. The person will also have to agree to the alternative supply.
The DHSC frequently reviews which medicines should be under an SSP and how long they need to be in place.
Any amendments or extensions to existing SSPs are documented on the NHS Business Services Authority website: Serious shortage protocols (SSPs) | NHSBSA.
Enquiries
For any queries on the details of this circular, please contact the Scottish Government Pharmacy Team at: PharmacyTeam@gov.scot.
Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, which were due to expire on 10 July 2026, have been extended until Friday 2 October 2026.
This Circular advises Health Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for ramipril 1.25mg capsules remains in place following an extension to its expiry date.
Update on Drug Tariff Part 11 clawback scale for community pharmacy contractors in Scotland from April 2026.
A Serious Shortage Protocol is in place for ramipril 1.25mg capsules from 22 April to 29 May 2026. Guidance for community pharmacies.
UK-wide Serious Shortage Protocols for Estradot® patches and Creon® capsules extended to 10 July 2026. Guidance for community pharmacies.
A new national PGD for oral candidiasis is being added to NHS Pharmacy First Scotland. Guidance for Health Boards and community pharmacy teams.
Scottish Government circular announcing a new Patient Group Direction for skin inflammation within NHS Pharmacy First Scotland.
UK‑wide Serious Shortage Protocols for Estradot patches and Creon 10000 capsules extended to 17 April 2026. Details for pharmacists included.
SSP withdrawal for Adipine® XL modified-release tablets, and Fixapost® preservative-free eye drops, originally due to expire on 6 February 2026, will now be withdrawn early
SSP extensions for Creon 10000 and 25000 have been issued. Pharmacists must review new end dates and continue limiting supply to one month.
SSP 086 for Latanoprost/Timolol eye drops is active 19 Dec 2025–6 Feb 2026. Guidance for pharmacists on substitution and patient care.
SSP 085 for Nifedipine 60mg tablets is active from 19 Dec 2025 to 6 Feb 2026. Guidance for pharmacists on substitution and patient care.
Serious Shortage Protocol for nifedipine (Adipine® XL) 30mg MR tablets in effect from 19 Dec 2025 to 6 Feb 2026. Full guidance for pharmacists.
This Circular advises Health Boards and community pharmacy contractors that four UK-wide Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches,
This Circular advises Health Boards and community pharmacy contractors that two UK-wide Serious Shortage Protocols (SSPs) for Creon® gastro-resistant capsules both due to expire on 21 November 2025 have been extended until Friday 16 January 2026.
The Scottish Government has released circular PCA(P)(2025)24 which details changes to the remuneration of all components of the NHS Pharmacy First (Scotland) service.
SSP for cefalexin oral suspension sugar free products extended to 28 November 2025. Pharmacists should review updated guidance.
SSPs for Estradot HRT patches extended to 5 Dec 2025. Pharmacists may substitute with Evorel or Estraderm MX. Review updated guidance.
Serious Shortage Protocols for cefalexin oral suspension sugar free products extended to 24 Oct 2025. Applies to SSP077 and SSP078. Review updated guidance.
Updated PGDs for UTIs and impetigo approved for NHS Pharmacy First Scotland. Health Boards to implement locally.
The Part 11 clawback rate has been reset to 0% from 1 July 2025. Future reviews will follow 2026/27 survey results. Full details in PCA(P)(2025)13.
Scottish pharmacy funding for 2025/26 confirmed at £343.3m, with a 4% uplift to the Global Sum and increased guaranteed income for key services.
SSPs for Estradot® HRT patches now end 10 Oct 2025. Pharmacists may substitute with Evorel® or Estraderm MX® to manage supply issues.
This circular reminds community pharmacy contractors of the key service requirements for NHS Pharmacy First Scotland, highlighting the importance of face-to-face consultations, correct use of NHS branding, and adherence to national service guidelines.
A Serious Shortage Protocol (SSP 083) is in effect from 23 June to 1 August 2025 for venlafaxine 37.5mg MR tablets, allowing substitution with capsules. Learn how pharmacists should manage this temporary supply issue.
SSPs for Estradot® HRT patches extended to 10 Oct 2025. Community pharmacy contractors are advised to note the updated expiry date.
This circular advises community pharmacy contractors on the amendments to the Drug Tariff Part 11 clawback scale.
New naloxone product added to emergency supply service. Updated service specification now available for community pharmacy teams.
SSPs for Estradot® and Creon® extended. Pharmacists advised of new expiry dates: 6 June 2025 for Estradot®, 21 Nov 2025 for Creon® capsules.
Scottish Government
The devolved government for Scotland has a range of responsibilities that include: the economy, education, health, justice, rural affairs, housing, etc...
The Serious Shortage Protocol for ramipril 1.25mg capsules has been extended until 30th October 2026. Read the latest guidance for pharmacies.